Efi Cohen-Arazi

Vascular Dynamics, Inc. provides blood pressure modulation devices. It develops and commercializes a passive, catheter-delivered implant for the treatment of hypertension. The company was founded in 2008 and is headquartered in Mountain View, CA.

GluSense Ltd. develops technology for Continuous Glucose Monitoring. The firm develops a miniature, Long-Term, Implantable Continuous Glucose Monitoring (CGM) system for diabetes patients, this system includes a miniature sensor implanted under the skin and an external wearable unit, e.g. a watch. Its wearable unit reads the signal from the implant and provides basic display and alarms. The company was founded by Yossi Gross in 2007 and is headquartered in Rehovot, Israel.

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

BlueWind Medical Ltd. develops and markets wireless neuro-stimulation devices for the treatment of peripheral neuropathic pain. It serves the medical industry. The company was founded in 2010 by Danny Neeman and is headquartered in Herzliya, Israel.

ChroniSense Medical Ltd. provides healthcare services. It develops wearable medical-grade devices that monitor vital signs and other health factors. The firm''s sensors measure medical data from blood oxygen and ECG to blood pressure, cardiac output and vascular resistance, and communicate that data to caregivers in real time. The company was founded by Danny B. Lange and Yossi Gross in 2015 and is headquartered in Yokneam, Israel.